Search Results - Haige Shen
- Showing 1 - 1 results of 1
-
1
A phase I randomized, double‐blinded, placebo‐controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects by Jason Lickliter, Shuang Wang, Wenxin Zhang, Huaqiang Zhu, Jing Wang, Congqiao Zhao, Haige Shen, Yu Wang
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book